DALLAS, May 13, 2025 /PRNewswire/ -- Scout, a premier provider of clinical trial services, has received the 2025 Patient Experience Innovation Award at the distinguished MedTech Breakthrough Awards. This marks Scout's impressive third consecutive win, following honors in 2023 and 2024, and coincides with their landmark 30th anniversary.This award honors Scout's Patient Liaison team, whose unwavering dedication redefines clinical trial patient support by combining tech-forward solutions with a human touch.Key to this success is the team's 24/7 multilingual support ensures patients receive immediate assistance, no matter their location or language. Scout's itinerary management simplifies logistics by coordinating travel, appointments, and step-by-step guidance—crucial for remote or cross-border participants.Scout's commitment to making the complex easier is clear in initiatives like the Scout Coordinator program for high-volume sites and the zero-fee ScoutPass card for patient payments. Their innovative approach and compassionate care advances patient experience and reinforces Scout's position as a trusted leader in the life sciences.About ScoutScout proudly celebrates 30 years of empowering clinical trials with people-first solutions through Scout Meetings, Scout Clinical, and Scout Academy. Operating in 100+ countries, we deliver face-to-face, virtual, and hybrid clinical meeting planning, patient payment, travel and logistics support, and virtual collaboration and education for top pharmaceutical and biotechnology companies. Learn more about our legacy at scoutclinical.com.About MedTech BreakthroughPart of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is an independent program devoted to honoring excellence in medical and health related technology companies, products, services and people

This innovative tech collaboration addresses emotional, logistical and financial challenges associated with international clinical trial recruitment, accelerating access to groundbreaking treatments globally.AMSTERDAM, April 15, 2025 /PRNewswire/ -- myTomorrows, a global health technology company connecting patients with all possible treatment options, has announced a new partnership with Scout, a leader in services and technology for the biopharmaceutical industry. Together, they aim to streamline and enhance cross-border patient recruitment for clinical trials. This will be achieved by addressing complex financial and logistical arrangements on behalf of patients, families, and caregivers, ensuring they are spared the challenges typically associated with accessing potential pre-approval treatments.Cross-border clinical research faces significant hurdles, from fragmented information systems and regulatory differences to complex visa and data privacy processes. Coupled with linguistic and cultural barriers, these challenges can impact communication and create delays. For rare disease trials or studies with strict eligibility criteria, they often prolong recruitment timelines, raise costs, and limit patient diversity, hindering access to developing therapies.Through this partnership, the patient journey is optimized by connecting trial matching to personalized domestic and cross-border support services. While myTomorrows' Patient Navigator team supports patients with initial trial option identification and pre-screening, the Scout Clinical service line offers services such as travel arrangements, expense reimbursements, pre-funded debit cards for out-of-pocket costs, and accommodation support, including short-term lodging and long-term housing for relocated patients and families